Ricard Ferrer

Cited by

	All	Since 2020
Citations	41229	30870
h-index	72	61
i10-index	235	205

7000

3500

1750

5250

20092010201120122013201420152016201720182019202020212022202320242025167 218 264 261 268 333 444 624 1359 2854 2696 3791 5440 6850 6753 6479 1349

Public access

View all

100 articles

8 articles

available

not available

Based on funding mandates

Co-authors

Juan Carlos Ruiz Rodriguez., MD PhDServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron, Barcelona, SpainVerified email at vallhebron.cat
Prof. Ignacio Martin-LoechesSt James's HospitalVerified email at tcd.ie
JOSE GARNACHO-MONTEROIntensive Care Clinical Unit. University Hospital Virgen Macarena Seviile, SpainVerified email at juntadeandalucia.es
Emilio MasedaVerified email at salud.madrid.org
Alejandro RodríguezCritical Care Department - Hospital Universitario de Tarragona Joan XXIIIVerified email at urv.cat
Erika P. Plata-MenchacaHospital Clinic Barcelona University HospitalVerified email at clinic.cat
Andrew RhodesVerified email at sgul.ac.uk
Torres AHospital Clinic Barcelona, Unversidad de Barcelona, Ciberes, IdibapsVerified email at ub.edu
Juan José González-LópezHospital Universitari Vall d'HebronVerified email at vhebron.net
Prof. Dr. med. Torsten BauerLungenklinik Heckeshorn, Helios Klinikum Emil von BehringVerified email at helios-gesundheit.de
massimo antonelliFondazione Policlinico Universitario A.Gemelli IRCCS, Università Cattolica del Sacro CuoreVerified email at unicatt.it
Nieves LarrosaJefe de Sección del Área de Bacteriologia y Micología del Servicio de Microbiología del HospitalVerified email at vhebron.net
Ferran BarbeHospital Arnau de Vilanova de Lleida. Catalonia. CIBERes ISCIII Madrid.Verified email at gencat.cat
Maurizio CecconiMaurizio Cecconi, MD FRCA FFICM MD(Res), Full Professor in Anaesthesia and Intensive Care MedicineVerified email at hunimed.eu
Matteo BassettiChair Infectious Diseases Clinic, University of Genoa and San Martino HospitalVerified email at unige.it
Jesus F Bermejo-Martin, 0000-0002-7...UNIVERSIDAD DE SALAMANCA, https://ror.org/02f40zc51Verified email at usal.es
Juan Carlos YebenesProfessor de Escola Superior de Ciencies de la Salut, Tecnocampus (UPF)Verified email at csdm.cat
Elie AzoulayUniversité Paris CitéVerified email at aphp.fr
Massimo GirardisUniversity of Modena & Reggio EmiliaVerified email at unimo.it
Zsolt MolnarProfessor in Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, HungaryVerified email at med.semmelweis-univ.hu

Ricard Ferrer

Intensive Care Department. Hospital Universitari Vall d’Hebron.

Verified email at vallhebron.cat

sepsis severe infections ARDS Covid-19


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ... Intensive care medicine 43, 304-377, 2017	11239	2017
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ... Critical care medicine 49 (11), e1063-e1143, 2021	5623	2021
Genomewide association study of severe Covid-19 with respiratory failure D Ellinghaus, F Degenhardt, L Bujanda, M Buti, A Albillos, P Invernizzi, ... The New England journal of medicine, 2020	2044*	2020
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program R Ferrer, I Martin-Loeches, G Phillips, TM Osborn, S Townsend, ... Critical care medicine 42 (8), 1749-1755, 2014	1784	2014
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain R Ferrer, A Artigas, MM Levy, J Blanco, G Gonzalez-Diaz, ... Jama 299 (19), 2294-2303, 2008	973	2008
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021	853	2021
Cristaloides y coloides en la reanimación del paciente crítico J Garnacho-Montero, E Fernández-Mondéjar, R Ferrer-Roca, ... Medicina intensiva 39 (5), 303-315, 2015	848	2015
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a … M Bassetti, R Echols, Y Matsunaga, M Ariyasu, Y Doi, R Ferrer, TP Lodise, ... The Lancet Infectious Diseases 21 (2), 226-240, 2021	679	2021
Fluid challenges in intensive care: the FENICE study: a global inception cohort study M Cecconi, C Hofer, JL Teboul, V Pettila, E Wilkman, Z Molnar, ... Intensive care medicine 41, 1529-1537, 2015	665	2015
Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study R Ferrer, A Artigas, D Suarez, E Palencia, MM Levy, A Arenzana, ... American journal of respiratory and critical care medicine 180 (9), 861-866, 2009	571	2009
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, ... The Lancet Respiratory Medicine 9 (6), 622-642, 2021	560	2021
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021	544	2021
The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study) A Rhodes, G Phillips, R Beale, M Cecconi, JD Chiche, D De Backer, ... Intensive care medicine 41, 1620-1628, 2015	497	2015
Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak E Azoulay, J De Waele, R Ferrer, T Staudinger, M Borkowska, P Povoa, ... Annals of intensive care 10, 1-8, 2020	446	2020
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021	391	2021
Surviving sepsis campaign: research priorities for sepsis and septic shock CM Coopersmith, D De Backer, CS Deutschman, R Ferrer, I Lat, ... Intensive care medicine 44, 1400-1426, 2018	374	2018
Albumin administration in the acutely ill: what is new and where next? JL Vincent, JA Russell, M Jacob, G Martin, B Guidet, J Wernerman, ... Critical care 18, 1-10, 2014	318	2014
Ventilator-associated pneumonia: incidence, risk factors, and microbiology. TT Bauer, R Ferrer, J Angrill, G Schultze-Werninghaus, A Torres Seminars in respiratory infections 15 (4), 272-279, 2000	311	2000
Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021 L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ... Critical care medicine 49 (11), 1974-1982, 2021	305	2021
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use P Schuetz, A Beishuizen, M Broyles, R Ferrer, G Gavazzi, EH Gluck, ... Clinical Chemistry and Laboratory Medicine (CCLM) 57 (9), 1308-1318, 2019	305	2019

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors